Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Air and Climate
- Energy
- Health and Safety
- University / Academia / Research
- Manufacturing, Other
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Agriculture
- Environmental
- Government
- Defense
- Paint
- Plastics & Resins
- Waste and Recycling
- Water and Wastewater
- Soil and Groundwater
- Food and Beverage
- Construction & Construction Materials
- Mining
- Banking & Finance / Insurance / Legal
- Electronics and Computers
- Glassware
- Retail
- Commercial
- Metal
- Printing
- Maritime/Shipbuild/Water Transport
Stem Cell Suppliers Serving Rwanda
166 companies found
Premium
based inDueren, GERMANY
Since 2005, NIPPON Genetics EUROPE has stood for innovation and quality in biotechnology. In these two decades, we have evolved from a supplier of high quality Japanese technologies to a developer of our own groundbreaking solutions. Our products ...
Enables long term cell storage at -80°C or -196°C. Improved cell recovery and viability after thawing. Ready-to-use freezing media – no programmed or sequential freezing required. Serum-free – no risk of contamination. GMP ...
based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Pursuing an Unmet Need in the Treatment of AML - SENTI-202 is designed to target and eliminate acute myeloid leukemia cells while sparing healthy bone marrow. Our vision is a potential medicine that does not rely on an invasive bone marrow ...
based inJena, GERMANY
We develop, manufacture and sell high-quality automated solutions for life sciences in a broad range of areas including molecular diagnostics, cancer and stem cell research, cell line development and bioprocessing. Our core competencies are in ...
The semi-solid media module was specifically developed for the isolation of bacteria and cell colonies as well as 3D clones from semi-solid and solid media (e.g. methylcellulose, matrigel, ...
based inLyon, FRANCE
Cellenion is a part of BICO. Our products aim to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry. ...
We offer a range of automated cloning solutions to suit even the most challenging cell line development ...
based inAustin, TEXAS (USA)
Direct Biologics is a leader in regenerative medicine, focusing on the development of next-generation bioactive products derived from stem cells. Their innovative technology centers on Extracellular Vesicle (EV) products, which are formulated from ...
Extracellular vesicles (EVs) are nature’s communication tool to coordinate activities between cells within your body. EVs are small lipid membrane-bound particles which contain molecular signals (proteins and RNA) that act like a message in a ...
based inSan Diego, CALIFORNIA (USA)
Lorem Cytori is committed to providing meaningful and quality therapeutic options with broad utility that benefit patients and healthcare providers around the world. Whether it’s advancing our product and technology pipeline, performing clinical ...
Cytori is developing cell therapies that harness the unique attributes of living cells that are present in an adult human patient’s own adipose (fat) tissue, also known as Adipose-Derived Regenerative Cells ...
based inBuffalo Grove, ILLINOIS (USA)
BIOLIFE4D is a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant – lifesaving technology that gives patients the gift of time. With ...
For years scientists and engineers have been using 3D printers to create objects out of metals and plastics. The 3D printing industry has become so big, in fact, that over the next few years its projected worth is expected to top $30 ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
Astrocytes, also known as Astroglia, belong to the family of glial cells in the human central and peripheral nervous system. They have been shown to have central roles in the maintenance of neuronal metabolism and neurotransmitter ...
based inRotkreuz, SWITZERLAND
Roche Diagnostics is a division of Roche. We develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, we offer the industry’s most comprehensive in vitro ...
Immunoassays for the qualitative detection of specific antibodies to Epstein-Barr virus (EBV). The Elecsys EBV panel consists of three immunoassaysto detect antibodies specific to the Epstein-Barr virus (EBV). The three assays, Elecsys EBV IgM, ...
based inSan Diego, CALIFORNIA (USA)
Cell Biolabs, Inc. proudly develops novel assays and reagents to advance cell and molecular biology. We are scientists driven by a devotion to discovery and innovation, and we work hard every day to find new ways to streamline life science research. ...
based inCypress, TEXAS (USA)
Sentry Air Systems designs and manufactures high quality air purification systems in order to provide engineering control devices for clean air for a variety of applications. Our patented line of quiet, compact and durable air cleaners offers simple ...
based inBellefonte, PENNSYLVANIA (USA)
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific ...
3dGRO® Human Colon Organoid Expansion Medium is a complete ready-to-use serum-free medium for the expansion and long-term culture of human colonic organoids. The medium has been validated for use with 3dGRO® Human iPSC Derived Colon ...
based inGolden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
MSC-GRO™ Humanized, Serum-Free Media has high growth and expansion rates for a variety of human mesenchymal stem cells and other cell lines. MSC-GRO™ Humanized, Serum-Free supports ...
based inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
based inLakewood, COLORADO (USA)
Terumo Blood and Cell Technologies is a global leader in blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries. As the only company with the unique combination of apheresis collections, manual ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
Aplastic anemia is a rare, but serious hematological disease caused by a failure or deficiency of the bone marrow to produce blood cells (erythrocytes, leukocytes, and platelets). Patients with aplastic anemia are at risk of ...
based inCambridge, MASSACHUSETTS (USA)
Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around ...
EDIT-301 is an experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). EDIT-301 consists of patient-derived ...
based inMadison, WISCONSIN (USA)
Mirus continued the development of a wide range of non-viral delivery technologies using proteins, polymers, and lipids in conjunction with novel chemistries that provided unique nucleic acid delivery capabilities. Our work at Mirus Bio began with a ...
This system is designed to be used with the Ingenio Electroporation Solution which is ideal for mammalian and insect cell transfection. Electroporation is the method of choice for many hard-to-transfect cell types, and the Ingenio EZporator ...
based inZossen, GERMANY
botiss biomaterials is an innovative, clinically and scientifically driven biotech company from Germany. Since the foundation of botiss biomaterials in 2009, we have become a leading developer, manufacturer and marketer of biomaterials for oral ...
maxresorb® is an innovative, safe, reliable, and fully synthetic bone substitute material that is characterized by controlled resorption properties and outstanding handling characteristics. maxresorb® is composed of 60% slowly resorbing ...
based inMannheim, GERMANY
faCellitate is a venture that originated from BASF’s incubator, Chemovator, and it provides interactive consumables for advanced cell technologies and regenerative medicine in the 3D cell culture market. Its unique polymeric platform aims at ...